AVH vs NAN

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

AVH

AVITA MED CDI 5:1 [AVH]

46LOW

NAN

NANOSONICS FPO [NAN]

46LOW

Score Breakdown

AVH NAN
Technical
58
61
Catalyst
50
50
Sentiment
50
50
Fundamental
68
87
Momentum
44
41
Risk Gate
46
40

Key Metrics

AVH Metric NAN
$177.5MMarket Cap$1.1B
264KAvg Volume (20d)1.1M
+0.1%Short Interest+11.7%
$3.18052-Week High$5.080
$1.00052-Week Low$3.210
+0.9%Daily Change+3.0%
$1.120Entry Price$3.615
N/AROE+10.1%
-67.8%Profit Margin+9.9%

Active Signals

AVH Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 4.3% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk

NAN Signals

●MACD momentum is picking up steam
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.3x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare AVH and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
AVH Full Analysis → NAN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).